18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer
One in four non‐small cell lung cancer (NSCLC) patients are diagnosed at an early‐stage. Following the results of the National Lung Screening Trial that demonstrated a survival benefit for low‐dose computed tomography screening in high‐risk patients, the incidence of early‐stage NSCLC is expected to...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-03-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.12978 |